skip to primary navigationskip to content

Professor James B. Rowe

Professor James B. Rowe

Professor of Cognitive Neurology

Department of Clinical Neurosciences, University of Cambridge

Director of Cambridge Centre for Frontotemporal Dementia and Related Disorders

Honorary Consultant Neurologist at CUH/CPFT

Wellcome Trust Fellow in Clinical Science

E-mail: james.rowe[at]


Cambridge Centre for Parkinson-Plus
Department of Clinical Neurosciences
University of Cambridge
Herchel Smith Building, Forvie Site
Robinson Way, Cambridge Biomedical Campus

Cambridge CB2 0SZ
Office Phone: 01223760696


If you are interested in a short biography of James B. Rowe please see here.

Research Interests

We are interested in what the fundamental mechanisms of Parkinson-Plus disorders, and especially progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), are.

Knowledge about mechanisms, biomarkers, and disease progression will be able to inform the development of better treatment options for patients and might eventually lead to finding a cure for Parkinson-Plus diseases.

We would like to understand how these different diseases lead to changes in the brain anatomy, in memory and cognitive function, and behaviour. In order to design novel tests for a better diagnosis and test novel drugs we are trying to find new biomarkers for these diseases and develop novel treatment strategies with the aim to halt the illness or treat specific symptoms.

A lot of our research involves brain imaging. We are using magnetic resonance imaging (MRI) but also positron emission tomography (PET) to determine the binding of radiomarkers to specific accumulating proteins or the amount of inflammation in the brain of patients with these diseases. Ultra-high-field MRI allows us to detect exceptionally fine grained details of structural and functional brain changes. A special method used in our Cambridge research is the use of magnetoencephalography (MEG) that allows us to study networks and responses in the brain, which is important to determine potential drug treatment options.

The  Cambridge Brain Bank is a very important partner for our research on Parkinson-Plus diseases as they determine the post mortem underlying pathologies of the brains donated by patients.

Key Publications

For publications please check here or visit my Google Scholar profile page.